| Literature DB >> 29242515 |
Jakub Wudarski1, Daniil Simanov1,2, Kirill Ustyantsev3, Katrien de Mulder2,4, Margriet Grelling1, Magda Grudniewska1, Frank Beltman1, Lisa Glazenburg1, Turan Demircan2,5, Julia Wunderer6, Weihong Qi7, Dita B Vizoso8, Philipp M Weissert1, Daniel Olivieri1,9, Stijn Mouton1, Victor Guryev1, Aziz Aboobaker10, Lukas Schärer8, Peter Ladurner6, Eugene Berezikov11,12,13.
Abstract
Regeneration-capable flatworms are informative research models to study the mechanisms of stem cell regulation, regeneration, and tissue patterning. However, the lack of transgenesis methods considerably hampers their wider use. Here we report development of a transgenesis method for Macrostomum lignano, a basal flatworm with excellent regeneration capacity. We demonstrate that microinjection of DNA constructs into fertilized one-cell stage eggs, followed by a low dose of irradiation, frequently results in random integration of the transgene in the genome and its stable transmission through the germline. To facilitate selection of promoter regions for transgenic reporters, we assembled and annotated the M. lignano genome, including genome-wide mapping of transcription start regions, and show its utility by generating multiple stable transgenic lines expressing fluorescent proteins under several tissue-specific promoters. The reported transgenesis method and annotated genome sequence will permit sophisticated genetic studies on stem cells and regeneration using M. lignano as a model organism.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29242515 PMCID: PMC5730564 DOI: 10.1038/s41467-017-02214-8
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Fig. 1Macrostomum lignano embryos are amenable to microinjection. a Schematic morphology and a bright-field image of an adult M. lignano animal. b Clump of fertilized eggs. c DIC image of a one-cell stage embryo. d Microinjection into a one-cell stage embryo. e Expression of GFP in the early embryo 3 h after injection with in vitro synthesized GFP mRNA. Scale bars are 100 μm
Efficiency of transgenesis with different reporter constructs and treatments
| Reporter | Injected line | Injected DNA | Irradiation treatment | Injected eggs | Positive hatchlings (%) | Germline transmission (%) | Established lines |
|---|---|---|---|---|---|---|---|
| EFA::eGFP | DV1 | PCR | — | 269 | 39 (14.50) | 5 (1.86) | NL1 |
| EFA::oGFP | DV1 | Plasmid | — | 114 | 28 (24.56) | 0 | — |
| EFA::oGFP | DV1 | Plasmid | 2.5 Gy | 42 | 13 (30.95) | 2 (4.76) | — |
| EFA::oGFP | DV1 | Fragment | 2.5 Gy | 102 | 4 (3.92) | 2 (1.96) | NL7 |
| EFA::oCherry | DV1 | Plasmid | 2.5 Gy | 80 | 4 (5.00) | 1 (1.25) | NL3 |
| EFA::oCherry | DV1 | Fragment | 2.5 Gy | 36 | 6 (16.67) | 3 (8.33) | NL4, NL5, NL6 |
| EFA::H2B::oGFP | DV1 | Fragment | 2.5 Gy | 38 | 10 (26.32) | 2 (5.26) | NL20 |
| ELAV4::oGFP | DV1 | Fragment | 2.5 Gy | 56 | 29 (51.79) | 2 (3.57) | NL21 |
| MYH6::oGFP | DV1 | Fragment | 2.5 Gy | 103 | 13 (12.62) | 1 (0.97) | NL9 |
| APOB::oGFP | DV1 | Fragment | 2.5 Gy | 65 | 2 (3.08) | 1 (1.54) | NL22 |
| CABP7::oGFP | DV1 | Plasmid | — | 20 | 2 (10.00) | 1 (5.00) | NL23 |
| CABP7::oNeon Green; ELAV4:: oScarlet-I | NL10 | Plasmid | — | 137 | 3 (2.19) | 2 (1.46) | NL24 |
Fig. 2Ubiquitously expressed elongation factor 1 alpha promoter transgenic lines. a NL1 line expressing enchanced GFP (eGFP). b NL3 line expressing codon-optimized Cherry (oCherry). c NL20 line expressing codon-optimized nuclear localized H2B::oGFP fusion. Right column—single cells from a macerated animal showing nuclear localization of GFP. FITC—FITC channel; DsRed—DsRed channel; BF—bright-field; Hoechst—DNA staining by Hoechst. Scale bars are 100 μm
Characteristics of Mlig_3_7 genome assembly
| Contigs | Scaffolds | |
|---|---|---|
| Total number | 5980 | 5270 |
| Total length | 762,843,491 | 764,424,962 |
| Average length | 127,565 | 145,052 |
| Shortest | 1370 | 3068 |
| Longest | 2,680,987 | 2,680,987 |
| N50 | 215,172 | 245,921 |
Characteristics of Mlig_RNA_3_7_DV.v1 transcriptome assembly
| Transcriptional units | Genes | |
|---|---|---|
| Number of transcripts | 66,777 | 72,846 |
| Total length | 206 Mb | 182 Mb |
| Number of non-redundant sequencesa | 33,715 | 44,328 |
| Total length of non-redundant sequencesb | 127 Mb | 133 Mb |
| Average transcript length | 3.8 kb | 3.0 kb |
| Shortest transcript | 104 nt | 151 nt |
| Longest transcript | 51,585 nt | 47,797 nt |
| Transcripts with single trans-splicing site | 18,894 (28.29%) | 28,273 (38.81%) |
| Transcripts with multiple trans-splicing sites | 4,596 (6.88%) | — |
| Transcripts with defined poly(A) site | 52,707 (78.93%) | 58,259 (79.98%) |
| TransRate score | 0.4360 | 0.4797 |
| Average gene length | 9.4 kb | 7.5 kb |
| Average number of introns per gene | 5.0 | 4.9 |
| Average intron length | 1.4 kb | 1.1 kb |
| Human homolog genes | — | 8006 |
| PFAM domains | — | 5819 |
| Eukaryotic BUSCOs ( | ||
| Complete | — | 98.1% |
| Fragmented | — | 1.0% |
| Missing | — | 0.9% |
aSequences with ≥ 95% identity at nucleotide level
bSequences with 100% amino acid identity of ORFs
Fig. 3Tissue-specific promoter transgenic lines. a NL9 line expressing GFP under the muscle-specific promoter of the MYH6 gene. Zoom in—detailed images of the body wall (top) and stylet (bottom); In situ—whole-mount in situ hybridization expression pattern of MYH6 transcript. b NL22 line expressing GFP under the gut-specific promoter of the APOB gene. Zoom in—detailed images of the gut side (top) and distal tip (bottom); In situ—whole-mount in situ hybridization expression pattern of the APOB transcript. c NL21 line expressing GFP under the testis-specific promoter of the ELAV4 gene. Zoom in—detailed images of the testis (top) and seminal vesicle (bottom); In situ—whole-mount in situ hybridization expression pattern of the ELAV4 transcript. d NL23 line expressing GFP under the ovary-specific promoter of the CABP7 gene. Zoom in—detailed image of the ovary and developing egg; In situ—whole-mount in situ hybridization expression pattern of the CABP7 transcript. e NL24 line expressing in a single construct NeonGreen under the testis-specific promoter of the ELAV4 gene and Scarlet-I under the ovary-specific promoter of the CABP7 gene. Zoom in—detailed images of the testis (top) and ovary (bottom) regions. FITC—FITC channel; DsRed—DsRed channel; BF—bright-field. Scale bars are 100 μm
Fig. 4Transgene expression during regeneration. a Testes-specific transgenic line NL23. b Ovaries-specific transgenic line NL22. BF—bright-field, FITC—FITC channel. Day 0—animals immediately after amputation, both head and tail regions are shown. Only regenerating head regions are subsequently followed. Scale bars are 100 μm
Fig. 5Variation of expression between different elongation factor 1 alpha transgenic lines. Fluorescence intensity is compared by taking images under the same exposure conditions at different exposure times (1.8 ms, 5 ms, 10 ms, and 50 ms). HUB1, NL1, NL7 – transgenic lines described in Table 1. FITC—FITC channel; BF—bright-field. Scale bars are 100 μm